Evidence map›Paper›PMID 32462422›Full record

ArticleClinical rheumatology2020

Navigating COVID-19 in the developing world.

Bridget Hodkinson, Prasun Singh, Ayanda Gcelu, Wilson Bautista-Molano, Guillermo Pons-Estel, Deshiré Alpízar-Rodríguez

Open access · bronzeAbstract readEditorial
In one paragraph

Article in Clinical rheumatology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.4field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Exploring the Impact of COVID-19 in Latin America.Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases · 2020
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 4 countries.

Bridget HodkinsonRheumatology, Department of Medicine, Groote Schuur Hospital and University of Cape Town, Cape Town, South Africa. drbridget@gmail.com.ORCID http://orcid.org/0000-0001-5360-9483
Prasun SinghRheumatology, Department of Medicine, Groote Schuur Hospital and University of Cape Town, Cape Town, South Africa.
Ayanda GceluRheumatology, Department of Medicine, Groote Schuur Hospital and University of Cape Town, Cape Town, South Africa.
Wilson Bautista-MolanoUniversity Hospital Fundación Santa Fé de Bogotá and Universidad El Bosque, Bogotá, Colombia.
Guillermo Pons-EstelCentro Regional de Enfermedades Autoinmunes y Reumáticas (CREAR), Grupo Oroño, Rosario, Argentina.
Deshiré Alpízar-RodríguezResearch Unit, Colegio Mexicano de Reumatología, Mexico City, Mexico.
University of Cape Town · ZAEl Colegio de México · MXHospital Provincial de Rosario · ARUniversidad El Bosque · CO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Developing CountriesAntirheumatic AgentsBetacoronavirusChloroquineCoronavirus InfectionsCOVID-19Delivery of Health CareHumansHydroxychloroquineImmunocompromised HostPandemicsPneumonia, ViralRheumatic DiseasesSARS-CoV-2TelemedicineAntirheumatic AgentsChloroquineHydroxychloroquine

Identifiers

PMID32462422
PMCPMC7251044
OpenAlexW3032557117

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.